File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/jgh.14937
- Scopus: eid_2-s2.0-85077029915
- PMID: 31734958
- WOS: WOS:000502469000001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A symptom severity questionnaire for patients suffering from functional gastrointestinal disorder: FGI‐Checklist
Title | A symptom severity questionnaire for patients suffering from functional gastrointestinal disorder: FGI‐Checklist |
---|---|
Authors | |
Keywords | functional dyspepsia functional gastrointestinal disorder gastroesophageal reflux disease irritable bowel syndrome psychometric |
Issue Date | 2020 |
Publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH |
Citation | Journal of Gastroenterology and Hepatology, 2020, v. 35 n. 7, p. 1130-1135 How to Cite? |
Abstract | Background and Aim: A well-validated, comprehensive checklist of functional gastrointestinal (FGI) disorder (FGID) symptom severity for tracking symptom profile changes over time is lacking. We aim to develop and validate a comprehensive symptom severity checklist for FGID. Methods: A 20-item scale, including both upper and lower gastrointestinal symptoms, was generated to measure the symptom severity commonly found in FGID. Patients who experienced at least monthly symptoms of FGID with negative endoscopy findings were invited to complete the FGI-Checklist, Patient Health Questionaire-9 for assessing depressive symptoms, and Patient Health Questionnaire-15 for assessing somatic symptoms at baseline. A subset of patients who met Rome III diagnostic criteria of gastroesophageal reflux disease, functional dyspepsia, and irritable bowel syndrome received medication treatment for 8–12 weeks and completed the FGI-Checklist again at a follow-up visit. Exploratory factor analysis was performed for subscales formation and psychometric properties were measured. Results: Six hundred and forty-one patients were recruited for current study and 108 (16.8%) of them completed the FGI-Checklist again at follow-up. Exploratory factor analysis identified a five-factor solution accounting for 66.8% of the total variance. The five factors are named esophageal syndrome, reflux syndrome, functional dyspepsia syndrome, nausea and vomiting syndrome, and abdominal and bowel syndrome. The FGI-Checklist total score correlated with Patient Health Questionaire-9 and Patient Health Questionnaire-15 (all P < 0.001), which demonstrated good construct validity. Good item-internal consistency was found (Cronbach's alphas: 0.69–0.87). Responsiveness for reflux syndrome subscale, functional dyspepsia syndrome subscale, and abdominal and bowel syndrome subscale after medication treatment was significant (paired-t-test: all P < 0.01). Conclusion: The instrument, Checklist, is valid and reliable. © 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
Persistent Identifier | http://hdl.handle.net/10722/290936 |
ISSN | 2023 Impact Factor: 3.7 2023 SCImago Journal Rankings: 1.179 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, Y | - |
dc.contributor.author | Cheong, PK | - |
dc.contributor.author | Fan, F | - |
dc.contributor.author | Cheung, CKY | - |
dc.contributor.author | Lan, LL | - |
dc.contributor.author | Yuen, KWK | - |
dc.contributor.author | Ching, JYL | - |
dc.contributor.author | Mak, ADP | - |
dc.contributor.author | Wu, JCY | - |
dc.date.accessioned | 2020-11-02T05:49:12Z | - |
dc.date.available | 2020-11-02T05:49:12Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Journal of Gastroenterology and Hepatology, 2020, v. 35 n. 7, p. 1130-1135 | - |
dc.identifier.issn | 0815-9319 | - |
dc.identifier.uri | http://hdl.handle.net/10722/290936 | - |
dc.description.abstract | Background and Aim: A well-validated, comprehensive checklist of functional gastrointestinal (FGI) disorder (FGID) symptom severity for tracking symptom profile changes over time is lacking. We aim to develop and validate a comprehensive symptom severity checklist for FGID. Methods: A 20-item scale, including both upper and lower gastrointestinal symptoms, was generated to measure the symptom severity commonly found in FGID. Patients who experienced at least monthly symptoms of FGID with negative endoscopy findings were invited to complete the FGI-Checklist, Patient Health Questionaire-9 for assessing depressive symptoms, and Patient Health Questionnaire-15 for assessing somatic symptoms at baseline. A subset of patients who met Rome III diagnostic criteria of gastroesophageal reflux disease, functional dyspepsia, and irritable bowel syndrome received medication treatment for 8–12 weeks and completed the FGI-Checklist again at a follow-up visit. Exploratory factor analysis was performed for subscales formation and psychometric properties were measured. Results: Six hundred and forty-one patients were recruited for current study and 108 (16.8%) of them completed the FGI-Checklist again at follow-up. Exploratory factor analysis identified a five-factor solution accounting for 66.8% of the total variance. The five factors are named esophageal syndrome, reflux syndrome, functional dyspepsia syndrome, nausea and vomiting syndrome, and abdominal and bowel syndrome. The FGI-Checklist total score correlated with Patient Health Questionaire-9 and Patient Health Questionnaire-15 (all P < 0.001), which demonstrated good construct validity. Good item-internal consistency was found (Cronbach's alphas: 0.69–0.87). Responsiveness for reflux syndrome subscale, functional dyspepsia syndrome subscale, and abdominal and bowel syndrome subscale after medication treatment was significant (paired-t-test: all P < 0.01). Conclusion: The instrument, Checklist, is valid and reliable. © 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd | - |
dc.language | eng | - |
dc.publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH | - |
dc.relation.ispartof | Journal of Gastroenterology and Hepatology | - |
dc.rights | Preprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Postprint This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | - |
dc.subject | functional dyspepsia | - |
dc.subject | functional gastrointestinal disorder | - |
dc.subject | gastroesophageal reflux disease | - |
dc.subject | irritable bowel syndrome | - |
dc.subject | psychometric | - |
dc.title | A symptom severity questionnaire for patients suffering from functional gastrointestinal disorder: FGI‐Checklist | - |
dc.type | Article | - |
dc.identifier.email | Cheung, CKY: ckyc@hku.hk | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/jgh.14937 | - |
dc.identifier.pmid | 31734958 | - |
dc.identifier.scopus | eid_2-s2.0-85077029915 | - |
dc.identifier.hkuros | 318305 | - |
dc.identifier.volume | 35 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 1130 | - |
dc.identifier.epage | 1135 | - |
dc.identifier.isi | WOS:000502469000001 | - |
dc.publisher.place | Australia | - |
dc.identifier.issnl | 0815-9319 | - |